Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic × ofatumumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma 3 Leukemia 3 Burkitt Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Autoimmune Diseases of the Nervous System 1 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1

Interventions

fludarabine 6 Whole-Body Irradiation 6 Cyclophosphamide 6 Mycophenolic Acid 5 fludarabine phosphate 4 Sirolimus 3 Cyclosporine 3 ibrutinib 2 acalabrutinib 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Cyclosporins 2 venetoclax 1 treosulfan 1 tafasitamab 1 selinexor 1 obinutuzumab 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Stem Cell Transplantation 1 Rituximab 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Patient Reported Outcome Measures 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡